Diminished Ovarian Reserve Clinical Trial
Official title:
Randomized Controlled Trial of Ovarian Function Following Intraovarian Injection of Platelet Rich Plasma for Women With Ovarian Aging
Consenting women with evidence of poor ovarian reserve will be randomly assigned to treatment with either Platelet Rich Plasma (PRP) or Platelet Poor Plasma (PPP).
As women age oocytes are gradually depleted with a consequent progressive loss of ovarian function and fertility. When a woman's follicle cohort falls below a critical level, she enters a transitional time of diminished ovarian reserve known as ovarian aging. Recently the use of autologous platelet-rich plasma (A-PRP) has been proposed as an additional strategy for improving ovarian function. A-PRP is prepared from autologous blood using an FDA approved device. The rationale for the use of PRP is that it contains growth factors which stimulate cellular anabolism, inflammatory modulators that create an anti-inflammatory effect and fibrinogen which acts as a scaffold for regenerating tissue. The investigators hypothesize that the growth factors present in PRP may have a beneficial effect promoting growth and recruitment of antral follicles. The investigators will recruit a prospective cohort of 90 patients with evidence of Premature Ovarian Aging/DOR. Women invited to participate in this RCT will have FSH above 12 and AMH below 1.0 ng/mL respectively and will have had fewer than 6 oocytes retrieved in a previous ovulation attempt. Consenting participants in this trial will be randomized in a doubly blind fashion to two groups. One will receive Platelet Rich Plasma (PRP) and the other will receive Platelet Poor Plasma (PPP). Women assigned to PPP will be offerred PRP in a future cycle if they so desire. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04972877 -
Effect of Electro-acupuncture on Women With Diminished Ovarian Reserve
|
N/A | |
| Recruiting |
NCT04447872 -
The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol
|
N/A | |
| Recruiting |
NCT05277948 -
Effect of Thumbtack Needle on Ovarian Function of Women With Diminished Ovarian Reserve (DOR)
|
N/A | |
| Recruiting |
NCT04711772 -
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve
|
||
| Recruiting |
NCT03670407 -
Follicular Activation by Fragmentation of Ovarian Tissue
|
N/A | |
| Recruiting |
NCT06072794 -
A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI)
|
Phase 1 | |
| Recruiting |
NCT06096766 -
the Correlation Between Ovarian Function and Serum Biomarkers
|
||
| Not yet recruiting |
NCT02099916 -
Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT06081257 -
The Effect of "KB-120" Small Molecular Nutrient in Women With Decreased Ovarian Reserve
|
N/A | |
| Recruiting |
NCT06426355 -
The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR
|
N/A | |
| Recruiting |
NCT04275700 -
Study of PRP in Women With Evidence of Diminished Ovarian Reserve
|
N/A | |
| Recruiting |
NCT06223178 -
Efficacy of Thumb-tack Needle Treatment for Diminished Ovarian Reserve
|
N/A | |
| Not yet recruiting |
NCT05577455 -
Efficacy of Traditional Chinese Medicine on Ameliorating IVF-ET Outcomes of Diminished Ovarian Reserve Patients
|
Phase 3 | |
| Not yet recruiting |
NCT05459493 -
A Clinical Study of Chinese Herbal Compound TJAOA101 in Therapy of Diminished Ovarian Reserve
|
Early Phase 1 | |
| Recruiting |
NCT05665010 -
Precise Stratification of Genetic Risk of Ovarian Function Impairment
|
||
| Not yet recruiting |
NCT05385848 -
Autologous Platelet-rich Plasma (PRP) Infusion to Improve Outcomes in Women With Ovarian Insufficiency: a Pilot Study
|
N/A | |
| Terminated |
NCT01614067 -
Delayed Start to Ovarian Stimulation
|
Phase 4 | |
| Recruiting |
NCT06395623 -
Study of Acupoints in Diminished Ovarian Reserve Based on Biological Characteristics
|
||
| Recruiting |
NCT05847283 -
DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT
|
N/A | |
| Recruiting |
NCT05485610 -
Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)
|
N/A |